[Mineralocorticoid receptor antagonists: inhibition of the renin angiotensin system]
- PMID: 20302183
- DOI: 10.1007/BF03366066
[Mineralocorticoid receptor antagonists: inhibition of the renin angiotensin system]
Similar articles
-
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension.Int J Cardiol. 2015 Dec 1;200:8-11. doi: 10.1016/j.ijcard.2014.10.150. Epub 2014 Oct 24. Int J Cardiol. 2015. PMID: 25466561 Review.
-
Selective aldosterone blockade with eplerenone in patients with congestive heart failure.Expert Opin Investig Drugs. 2003 Aug;12(8):1423-7. doi: 10.1517/13543784.12.8.1423. Expert Opin Investig Drugs. 2003. PMID: 12882627 Review.
-
ARAs to the RESCUE.J Am Soc Hypertens. 2016 Mar;10(3):187-8. doi: 10.1016/j.jash.2016.01.014. J Am Soc Hypertens. 2016. PMID: 27408946 No abstract available.
-
Hypertension, angiotensin II, aldosterone, and race.J Am Coll Cardiol. 2003 Apr 2;41(7):1156-8. doi: 10.1016/s0735-1097(03)00053-6. J Am Coll Cardiol. 2003. PMID: 12679216 No abstract available.
-
Evaluation of the aldosterone-blocking agent eplerenone in hypertension and heart failure.Expert Opin Pharmacother. 2007 Dec;8(17):3053-9. doi: 10.1517/14656566.8.17.3053. Expert Opin Pharmacother. 2007. PMID: 18001264 Review.
Cited by
-
Eplerenone for hypertension.Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD008996. doi: 10.1002/14651858.CD008996.pub2. Cochrane Database Syst Rev. 2017. PMID: 28245343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical